Harrington Discovery Institute at University Hospitals and the Alzheimer’s Drug Discovery Foundation (ADDF) announce a joint request for proposals for the 2019 ADDF-Harrington Scholar Award. The ADDF-Harrington Scholar Award is designed to accelerate the translation of innovative research that could treat, prevent, or slow Alzheimer’s disease or related dementias. This year’s RFP seeks programs that focus on proteostasis targets in addition to other novel approaches for Alzheimer’s disease and related dementias.
“This is our sixth year of collaborating with the Harrington Discovery Institute to offer this unique opportunity, giving researchers access to both funding resources as well as a team of industry experts for project support,” says Howard Fillit, MD, Founding Executive Director and Chief Science Officer at the ADDF. “This year’s award will…
